CADTH seeks patients’ perspectives to improve the relevance and quality of our reviews. Also, to enable those possibly affected by the reviews to have an opportunity to contribute to them. For reimbursement reviews and provisional funding algorithms CADTH invites patient groups to contribute input relevant input and feedback.
Reimbursement Reviews
Steps for Providing Patient Input
To seek public reimbursement for a drug, a pharmaceutical company applies to CADTH. CADTH issues an open call for patient input. CADTH sends out notifications for these open calls every Thursday, through its CADTH Weekly Update. Calls for patient input are also highlighted on the open calls page of the CADTH website.
To participate:
- Review the Guidance for Providing Patient Input for information about the type of input CADTH is requesting and how it will be incorporated into the reimbursement review process.
- Download the Patient Input Template.
- Complete the template by the deadline given on the Open Calls page.
- Send the completed template by using the Submit link next to the drug, plasma product, or cell and gene therapy listed on the Open Calls page.
Steps for Providing Feedback on Draft Recommendations
Following CADTH’s review and expert committee deliberations, draft reimbursement recommendations are shared for feedback. Only patient groups who contributed input on the drug, plasma product, or cell and gene therapy under review can provide feedback on the draft recommendation. New draft recommendations and open calls for feedback are highlighted in the CADTH Weekly Update.
To participate:
- Download the appropriate template:
- stakeholder feedback on a pERC initial recommendation (use for cancer drugs filed before October 2020)
- stakeholder feedback on draft recommendation (effective for all drugs targeting April 2021 expert committee meetings)
- Complete the feedback form by the deadline on the Open Calls page.
- Submit the completed form by using the Submit link next to the drug, plasma product, or cell and gene therapy on the Open Calls page.
Provisional Funding Algorithms for Oncology Drugs
Steps for Providing Patient Input
CADTH issues a call for stakeholder input for all provisional funding algorithm projects. Open calls for input are highlighted in the CADTH Weekly Update.
To provide initial input at the outset of the provisional funding algorithm project:
- Locate the webpage for provisional algorithm project of interest from the CADTH Weekly Update or the list of current opportunities for input and feedback.
- Review the proposed project scope for the provisional algorithm.
- Download the stakeholder input template.
- Complete the template by the deadline specified on the project webpage.
- Send the completed template by clicking Submit Feedback on the project webpage.
Steps for Providing Feedback
CADTH issues a call for stakeholder feedback on all draft provisional funding algorithms. Open calls for feedback are highlighted in the CADTH Weekly Update.
To provide stakeholder feedback on a draft provisional funding algorithm:
- Locate the webpage for provisional algorithm project of interest from the CADTH Weekly Update or the list of current opportunities for input and feedback.
- Review the draft provisional funding algorithm report.
- Download the stakeholder feedback template.
- Complete the template by the deadline specified on the project webpage.
- Send the completed template by clicking Submit Feedback on the project webpage.
Questions and Comments
If you have questions or need help to participate, please contact PatientEngagement@cadth.ca or call CADTH at 1 866 988 1444.
To learn more about CADTH reimbursement review process, you can to the Procedures for CADTH Reimbursement Reviews.